EANS-Adhoc: LifeWatch AG / LifeWatch to report on Fourth Quarter and Full Fiscal Year 2012 Results on February 26, 2013 (with

PR Newswire/euro adhoc/
EANS-Adhoc: LifeWatch AG / LifeWatch to report on Fourth Quarter and Full Fiscal
Year 2012 Results on February 26, 2013 (with document)
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 
Annual Reports/quarterly report/ Invitation to Analyst and Media Conference
06.02.2013 
- Press release and Letter to Shareholders at 7:00 a.m. CET (01:00 a.m. EST)
- Analyst and Media Conference in Zurich at 10:00 a.m. CET
- International Conference Call / Audio web cast at 10:00 a.m. CET    
Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE)
will report on its results for the fourth quarter 2012 and full fiscal year 2012
on Tuesday, February 26, 2013. 
You will find a PDF-version of this press release and of the registration form
at the end of this message.  
Press release and Letter to Shareholders at 7:00 a.m. CET (1:00 a.m. EST)
LifeWatch will publish internationally the results for the fourth quarter 2012
and full fiscal year 2012 in a press release and letter to shareholders
at 7:00 a.m. CET. 
Analyst and media conference at 10:00 a.m. CET 
LifeWatch will report on the fourth quarter and full fiscal year 2012 results at
an English-speaking analyst and media conference that will take place in
Zurich on  
Tuesday, February 26, 2013; at 10:00 a.m. CET
at the Zunfthaus zur Saffran, Limmatquai 54, 8001 Zurich/Switzerland 
Please confirm your participation at the analyst and media conference by
returning the registration form by Friday, February 22, 2013.  
International conference call / audio web cast at 10:00 a.m. CET  
At 10:00 a.m. CET, LifeWatch will also discuss the results in a conference call
and audio web cast which will be accompanied by presentation visuals. The
conference call is also accessible as an audio web cast in the Investor
Relations section of the LifeWatch website www.irlifewatch.com where an archived
version will remain available for download.  
The local dial-in numbers for the conference call are as follows:
+ 41 (0)91 610 56 00 (Europe)
+ 44 (0)203 059 58 62 (UK)
+ 1 (1)866 291 41 66 (USA - Toll-free)  
All participants are requested to dial in at least ten minutes prior to the
call. No PIN is required to access the call. 
end of ad-hoc-announcement
================================================================================
About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss
Exchange (LIFE), Switzerland, is the leading healthcare technology and solution
company, specializing in advanced telehealth systems and wireless remote patient
monitoring services. LifeWatch services cater to individuals, ranging from
high-risk and chronically ill patients, to consumers of health and wellness
products. LifeWatch AG has operative subsidiaries in the United States, in
Switzerland and in Israel and is the parent company of LifeWatch Services Inc.,
and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading US-based
provider of cardiac monitoring services and home sleep testing of Obstructive
Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading
developer and manufacturer of telemedicine products. The Company is planning to
introduce the LifeWatch V, an Android-based smartphone with medical sensors and
apps that uses a cloud-based service platform. For additional information,
please visit www.lifewatch.com. 
Sign-up for customized E-mail alerts and documentation requests is available at
http://production.investis.com/lifewatch/alert-service/ 
This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position,
business strategy and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short term and long term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.  
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE
AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES
OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS.  ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED
STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH
AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION
ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE
ISSUER. 
Further inquiry note:
For further information please contact:
Sensus Communication Consultants, Zürich
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch 
Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/Ojrskc2e
http://resources.euroadhoc.com/us/YxkzoEfd 
issuer:      LifeWatch AG 
         Rundbuckstrasse 6 
         CH-8212 Neuhausen am Rheinfall
phone:       +41 52 632 00 50
FAX:         +41 52 632 00 51
mail:        users@lifewatch.com
WWW:         www.lifewatch.com
sector:      Healthcare Providers
ISIN:        CH0012815459
indexes:     SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard: 
         SIX Swiss Exchange 
language:   English 
    
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- Feb/06/2013 16:36 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.